Open Access
CC BY 4.0 · Appl Clin Inform
DOI: 10.1055/a-2595-0317
Case Report

Special Issue on CDS Failures: A Measurement Science Framework to Optimize CDS for Opioid Use Disorder Treatment in the ED

Mark Samuel Iscoe
1   Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, United States
2   Emergency Medicine, Yale School of Medicine, New Haven, United States
,
Carolina Diniz Hooper
2   Emergency Medicine, Yale School of Medicine, New Haven, United States
,
Deborah R Levy
3   PRIME Center, VA Connecticut Healthcare System PRIME Center, West Haven, United States (Ringgold ID: RIN584021)
,
John Lutz
4   Yale School of Medicine, New Haven, United States
,
Hyung Paek
5   Department of Biostatistics (Health Informatics), Yale University School of Public Health, New Haven, United States (Ringgold ID: RIN50296)
,
Christian Rose
6   Department of Emergency Medicine, Stanford University School of Medicine, Stanford, United States (Ringgold ID: RIN10624)
,
Thomas Kannampallil
7   Anesthesiology/Institute for Informatics, Washington University in Saint Louis, Saint Louis, United States (Ringgold ID: RIN7548)
,
Daniella Meeker
8   Biomedical Informatics and Data Sciences, Yale School of Medicine, New Haven, United States
,
James Dziura
2   Emergency Medicine, Yale School of Medicine, New Haven, United States
9   Department of Biostatistics (Health Informatics), Yale School of Medicine, New Haven, United States
,
Edward R Melnick
10   Emergency Medicine, Yale School of Medicine, New Haven, United States (Ringgold ID: RIN12228)
› Author Affiliations

Supported by: National Institute on Drug Abuse R33DA059884
Preview

Objectives: In the EMergency department-initiated BuprenorphinE for opioid use Disorder (EMBED) trial, a clinical decision support (CDS) tool had no effect on rates of buprenorphine initiation in emergency department (ED) patients with opioid use disorder. The Agency for Healthcare Research and Quality (AHRQ) recently released a CDS Performance Measure Inventory to guide data-driven CDS development and evaluation. Through partner co-design, we tailored AHRQ inventory measures to evaluate EMBED CDS performance and drive improvements. Methods: Relevant AHRQ inventory measures were selected and adapted using a partner co-design approach grounded in consensus methodology, with three iterative, multidisciplinary partner working group sessions involving stakeholders from various roles and institutions; meetings were followed by post-meeting surveys. The co-design process was divided into conceptualization, specification, and evaluation phases building on the Centers for Medicare and Medicaid Services’ measure life cycle framework. Final measures were evaluated in 3 EDs in a single health system from 1/1/2023-12/31/2024. Results: The partner working group included 25 members. During conceptualization, 13 initial candidate metrics were narrowed to 6 priority categories. These were further specified and validated as the following measures, presented with preliminary values based on use of the current (i.e., pre-optimization) EMBED CDS: eligible encounters with CDS engagement, 5.0% (95% CI: 4.3-5.8%); teamwork on ED initiation of buprenorphine, 39.9% (32.5%-47.3%); proportion of eligible users who used EMBED, 58.3% (50.9%-65.8%); time spent on EMBED 29.0 seconds (20.4-37.7 seconds); proportion of buprenorphine orders placed through EMBED, 6.5% (3.4%-9.6%); and task completion, 13.8% (8.9%-18.7%) for buprenorphine order/prescription. Conclusions: A measurement science framework informed by partner co-design was a feasible approach to develop measures to guide CDS improvement. Subsequent research could adapt this approach to evaluate other CDS applications.



Publication History

Received: 18 February 2025

Accepted after revision: 21 April 2025

Accepted Manuscript online:
20 August 2025

© . The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany